In HCC, several critical molecules involved in the multi-step process of glucose metabolism have been characterized as biomarkers for prognosis prediction and therapeutic selection, such as LDH [40], PKM2 [41], and PGK1 [42]. The gene discussed is PKM; the disease is hepatocellular carcinoma.